Beta lactamase as biomarker for the specific detection of tuberculosis-complex bacteria
MetadataShow full item record
The present disclosure provides methods, reagents, systems, and devices that target β lactamase as a biomarker for the sensitive and specific detection of tuberculosis-complex bacteria. Specifically, the present disclosure relates to methods and compositions for the detection of specific β-lactamase protein and nucleic acid sequences to indicate the presence of tuberculosis-complex bacteria.
Cirillo, Jeffrey D.; Norman, Michael T. (2019). Beta lactamase as biomarker for the specific detection of tuberculosis-complex bacteria. United States. Patent and Trademark Office; Texas A&M University. Libraries. Available electronically from